✦ LIBER ✦
9119 POSTER Combination of Pertuzumab and Erlotinib as 2nd-/3rd-Line (2/3L) Treatment for Patients (pts) With Metastatic Non-Small Cell Lung Cancer (NSCLC) – Safety and Anti-Tumour Activity by FDG-PET/CT Imaging Changes
✍ Scribed by Hughes, B.; Mileshkin, L.; Townley, P.; Gitlitz, B.; Eaton, K.; Mitchell, P.; Hicks, R.; Loecke, D.; Amler, L.; Pirzkall, A.
- Book ID
- 122648940
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 40 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.